news MAIT immune cells revealed as key in toxic shock development 26 November 2019 | By Victoria Rees (Drug Target Review) Researchers have found that MAIT immune cells respond rapidly to group A streptococcal infection, causing inflammation and toxic shock, which presents a therapeutic target.
news Streptococcal toxic shock syndrome vaccine candidate developed 4 September 2019 | By Victoria Rees (Drug Target Review) Researchers have created a vaccine to treat and prevent streptococcal toxic shock syndrome which showed success in mice models.